Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Takeda

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|July 30, 2008
Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in miceYoshito Takeda, Ping He, Isao Tachibana, et al.
The Journal of Pathology|May 20, 2005
Propionibacterium acnes-induced hepatic granuloma formation is impaired in mice lacking tetraspanin CD9Hiroyuki Yamane, Isao Tachibana, Yoshito Takeda, et al.
Angiogenesis|September 30, 2021
Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxel therapy after immunotherapy: a case reportKinnosuke Matsumoto, Takayuki Shiroyama, Noriyasu Hashida, et al.
Respiratory Medicine Case Reports|March 7, 2022
A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunityYuta Nakagawa, Kinnosuke Matsumoto, Makoto Yamamoto, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2015
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancerYuhei Kinehara, Toshiyuki Minami, Takashi Kijima, et al.
Scientific Reports|August 23, 2023
A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19Kota Iwahori, Takuro Nii, Norihiko Yamaguchi, et al.
Internal Medicine (Tokyo, Japan)|June 10, 2026
Mycobacterium brisbanense Pulmonary Disease Treated with a Macrolide-Based Multidrug Regimen: A Case ReportYuki Nakaya, Kazuki Hashimoto, Kiyoharu Fukushima, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2023
T cell immunity in interstitial lung disease with non-small cell lung cancer patientsTomomi Isono, Kota Iwahori, Masahiro Yanagawa, et al.
BMC Cancer|July 7, 2022
CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I studyTomoyuki Otsuka, Sumiyuki Nishida, Takayuki Shibahara, et al.
DNA and Cell Biology|September 23, 2006
The extracellular domain of p185(c-neu) induces density-dependent inhibition of cell growth in malignant mesothelioma cells and reduces growth of mesothelioma in vivoTsutomu Yoneda, Toru Kumagai, Izumi Nagatomo, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|July 30, 2008
Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in miceYoshito Takeda, Ping He, Isao Tachibana, et al.
The Journal of Pathology|May 20, 2005
Propionibacterium acnes-induced hepatic granuloma formation is impaired in mice lacking tetraspanin CD9Hiroyuki Yamane, Isao Tachibana, Yoshito Takeda, et al.
Angiogenesis|September 30, 2021
Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxel therapy after immunotherapy: a case reportKinnosuke Matsumoto, Takayuki Shiroyama, Noriyasu Hashida, et al.
Respiratory Medicine Case Reports|March 7, 2022
A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunityYuta Nakagawa, Kinnosuke Matsumoto, Makoto Yamamoto, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2015
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancerYuhei Kinehara, Toshiyuki Minami, Takashi Kijima, et al.
Scientific Reports|August 23, 2023
A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19Kota Iwahori, Takuro Nii, Norihiko Yamaguchi, et al.
Internal Medicine (Tokyo, Japan)|June 10, 2026
Mycobacterium brisbanense Pulmonary Disease Treated with a Macrolide-Based Multidrug Regimen: A Case ReportYuki Nakaya, Kazuki Hashimoto, Kiyoharu Fukushima, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2023
T cell immunity in interstitial lung disease with non-small cell lung cancer patientsTomomi Isono, Kota Iwahori, Masahiro Yanagawa, et al.
BMC Cancer|July 7, 2022
CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I studyTomoyuki Otsuka, Sumiyuki Nishida, Takayuki Shibahara, et al.
DNA and Cell Biology|September 23, 2006
The extracellular domain of p185(c-neu) induces density-dependent inhibition of cell growth in malignant mesothelioma cells and reduces growth of mesothelioma in vivoTsutomu Yoneda, Toru Kumagai, Izumi Nagatomo, et al.
Pageof 15